Healthcare & Life Sciences
Ambros Therapeutics
United Statesambrostherapeutics.com
Ambros Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About Ambros Therapeutics
Based in the United States, Ambros Therapeutics is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Ambros Therapeutics is a clinical-stage biotechnology company developing neridronate, a third-generation bisphosphonate drug candidate, for the treatment of Complex Regional Pain Syndrome Type 1 (CRPS-1), a rare and debilitating pain condition with no FDA-approved therapies.
Explore Ambros Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.